DI NOTO, Laura
DI NOTO, Laura
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)”
2009-01-01 Palmeri, L; Vaglica, M; Mangiameli, A; Di Noto, L; Bongiovanni, A; Marchese, A; Palmeri, S
"Weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF is active in advanced gastroesophageal (GE) and gastric (G) cancer: results of a phase II study”
2005-01-01 PALMERI S; MC MACALUSO; MVAGLICA; GMODICA; LDI NOTO; GDI VITA; CSCIUM; GVETRI; EVASSALLO; GDI GES
Analisi della frequenza del polimorfismo 1249-1250insACAA del gene TGF-beta2 in un gruppo di pazienti affette da carcinoma della mammella.
2005-01-01 NUZZO D; SCOLA L; CANDORE G; DI NOTO L; BONGIOVANNI A; VAGLICA M; CRIVELLO A; FORTE GI; GIACALONE A; CARUSO C; LIO D; PALMERI S; Scola, L.
Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant eligible newly diagnosed multiple myeloma: a multicentre real-world experience
2024-10-31 Porrazzo, Marika; Moscato, Tiziana; Sapienza, Giuseppe; Accardi, Fabrizio; Patti, Caterina; Cangialosi, Clotilde; Costanza, Carmelo; Bono, Roberto; Tringali, Stefania; Rotolo, Cristina; Gigliotta, Emilia; Rizzuto, Andrea; Ingrascè, Manuela Giuseppa; Butera, Giulia; Di Noto, Laura; Santoro, Alessandra; Marfia, Anna; Botta, Cirino; Siragusa, Sergio; Martino, Massimo; Castagna, Luca
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients
2006-01-01 PALMERI S; A SAETTA; MC MACALUSO; M VAGLICA; CM PORRETTO; L PALMERI; L DI NOTO; A ACCARDO; C RAIMONDI; A BONGIOVANNI; P GIGLIONE; E VASSALLO
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis
2010-01-01 Palmeri,L; Matranga,D; Vaglica,M; Di Noto,L; Bongiovanni,A; Marchese,A; Ancona,C; Frazzetta,M; Cajozzo,M; Palmeri,S
“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)”
2006-01-01 PALMERI S; AMANGIAMELI; MVAGLICA; RALLEGRO; MC MACALUSO; ABONGIOVANNI; L DI NOTO; DVASTA; LRACITI; DLIO
“Cytokine gene polymorphisms and breast cancer susceptibility”
2006-01-01 Scola,L; Vaglica,M; Crivello,A; Palmeri,L; Forte,GI; Macaluso,MC; Giacalone,A; Di Noto,L;Bongiovanni,A; Raimondi,C;Accardo, A;Verna,R;Candore,G;Caruso,C;Lio,D;Palmeri S
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study”
2009-01-01 Palmeri, L; Vaglica, M; Mangiameli, A; Di Noto, L; Bongiovanni, A; Marchese, A; Palmeri, S
“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)”
2009-01-01 Palmeri, L; Di Noto, L; Vaglica, M; Bongiovanni, A; Iannitto, E; Palmeri, S
“High efficacy of the CHOP + Rituximab association in a case of primary rectal non Hodgkin lymphoma (NHL)”
2006-01-01 E VASSALLO; L DI NOTO; LPALMERI; M VAGLICA; G PANCERA; PALMERI S
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma”
2006-01-01 Crivello, A; Giacalone, A; Vaglica, M;Scola, L; Forte, GI;Macaluso, MC; Raimondi, C; Di Noto, L; Bongiovanni, A; Accardo, A; Candore, G;Palmeri, L;Verna, R; Caruso, C;Lio, D;Palmeri S
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)”
2008-01-01 PALMERI L; MANGIAMELI A; VAGLICA M; FRAZZETTA M; VETRI G; DI NOTO L; RAIMONDI C; ACCARDO A; BONGIOVANNI A; INTRIVICI C; PALMERI S